Effects of Beta-alanine Supplementation and High Intensity Interval training among Recreationally Active Females by Yarbrough, Mary E
Georgia Southern University 
Digital Commons@Georgia Southern 
Electronic Theses and Dissertations Graduate Studies, Jack N. Averitt College of 
Summer 2016 
Effects of Beta-alanine Supplementation and High 
Intensity Interval training among Recreationally Active 
Females 
Mary E. Yarbrough 
Follow this and additional works at: https://digitalcommons.georgiasouthern.edu/etd 
 Part of the Exercise Physiology Commons, Laboratory and Basic Science Research 
Commons, and the Other Nutrition Commons 
Recommended Citation 
Yarbrough, Mary E., "Effects of Beta-alanine Supplementation and High Intensity Interval 
training among Recreationally Active Females" (2016). Electronic Theses and Dissertations. 
1457. 
https://digitalcommons.georgiasouthern.edu/etd/1457 
This thesis (open access) is brought to you for free and open access by the Graduate Studies, Jack N. 
Averitt College of at Digital Commons@Georgia Southern. It has been accepted for inclusion in 
Electronic Theses and Dissertations by an authorized administrator of Digital Commons@Georgia 
Southern. For more information, please contact digitalcommons@georgiasouthern.edu. 
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INTERVAL TRAINING AMONG RECREATIONALLY ACTIVE FEMALES 
by 
MARY ELIZABETH YARBROUGH 
(Under the direction of John Dobson) 
 
ABSTRACT 
Beta-alanine is a non-essential amino acid that when combined with L-histidine forms the 
dipeptide carnosine.  Recent research has shown that supplementary intake of beta-alanine can 
substantially increase carnosine content in muscle fibers and has been associated with attenuating 
fatigue and enhancing high intensity exercise performance.  The aim of this study was to 
examine the effects of 4 weeks of beta-alanine supplementation combined with high intensity 
interval training (HIIT) on indices of aerobic and anaerobic performance, rowing performance, 
and body composition.  Twenty-one recreationally active females (22.2 ± 2.2 yrs.) participated in 
a double blind, placebo controlled study and were randomly assigned to one of 3 groups: beta-
alanine (BA, n = 8), placebo (PLA, n = 7), or control (CON, n = 6).  Prior to and following 4 
weeks of supplementation all groups had anthropometric measurements done and body 
composition was determined using dual energy x-ray absorptiometry (DEXA).  Participants also 
performed a graded exercise test on the rowing ergometer to determine VO2 peak, ventilatory 
threshold (VT), and time to exhaustion (TTE).  Additionally, participants came back to the lab to 
complete a 1,000 m time trial (TT) to determine time for completion and peak power output 
(PPO).  During the 4 week intervention the BA and PLA groups completed a 7 minute 1: 1 
(work: recovery) HIIT protocol that was a pre-determined workload whilst consuming either 6.4 
g/day of BA or PLA.  All three groups showed significant improvements from pre to post testing 
in VO2 peak, TTE, VT, TT, PPO and a reduction in total BF% in arms (p ≤ 0.05).  While several 
of the variables had significant interactions between groups: VO2 peak, TTE, TT, PPO, BF% 
legs, and BF% trunk, (p ≤ 0.05),  post hoc testing revealed that peak power output was the only 
the variable that showed a significant difference between the BA and PLA groups as compared 
to the CON group during post testing (p = 0.00).  The results of this study suggest that HIIT can 
enhance measures of aerobic capacity and increase PPO, while beta-alanine supplementation did 
not seem to have much of an effect on training. 
INDEX WORDS: Carnosine, Beta-alanine, Rowing, Time trial, Peak power output, Aerobic capacity, 
Ventilatory threshold 
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CHAPTER I 
INTRODUCTION 
 
Rowing is a full body workout and when rowers are completing a 2,000 meter race in ~6-
8 minutes and is dependent on the capacity of both the aerobic and anaerobic energy pathways.  
Some training strategies might involve ergogenic aids such as high intensity interval training or 
supplementing with beta-alanine.  Beta-alanine has been shown to increase muscle carnosine 
content and muscle buffering capacity, while high intensity interval training has been shown to 
improve anaerobic and aerobic fitness. 
Beta-alanine (BA) is a nonessential amino acid that can combine with L-histidine to form 
the cytoplasmic dipeptide carnosine (β-alanyl-L-histidine).  In humans, the rate of carnosine 
synthesis in skeletal muscle is limited by the availability of beta-alanine.  Carnosine is found at 
highest concentrations in skeletal muscle and can act as an intracellular buffer during high 
intensity exercise, the mechanism of carnosine presumably relates to its characteristics as a 
calcium sensitizer (Dutka et al., 2011).  There are several determinants of muscle carnosine 
concentrations including: gender, age, muscle fiber type, diet, supplementation, and exercise 
training (Sale, 2013).  According to Dutka and colleagues (2011), carnosine concentrations in 
skeletal muscle are almost twice as high in fast-twitch (type II) fibers as slow twitch (type I) 
fibers.  Harris and colleagues (2006) found that oral supplementation of beta-alanine can 
considerably elevate carnosine concentration in humans.  The increases in carnosine 
concentration within the muscle are associated with performance enhancements, such as 
buffering capacity, increased power, and delay in time to fatigue.  Several studies have shown 
that beta-alanine supplementation can increase muscle carnosine ~45-60% after 4 weeks of 
supplementation and can improve anaerobic capacity and muscle function during high intensity 
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exercise (Harris et al., 2006; Derave et al., 2007).  Increases in carnosine concentration through 
regular supplementation with beta-alanine may improve muscle buffering capacity and delay the 
onset of fatigue during intense exercise (Walter, 2010).  Currently, the only known adverse 
effects of beta-alanine supplementation are the symptoms of parasthesia, which are triggered by 
high and acute single doses and typically disappear within approximately an hour after ingestion 
(Harris, 2006).  Parasthesia is defined as a skin sensation, such as burning, prickling, itching, or 
tingling, with no apparent physical cause.  Considering that beta-alanine is an amino acid that 
naturally plays a relevant role in the human body and that doses studied so far are quite similar to 
that found in diet, it is likely that this supplement is safe (Artioli, 2010).  Based off of previous 
studies, supplementing with beta-alanine for four or more weeks can evoke significant changes 
in exercise performance or capacity especially during high intensity exercise or when 
performance is likely to be limited by hydrogen ions in skeletal muscle (Sale, 2013). 
High-intensity interval exercise results in diminished stores of adenosine tri-phosphate 
(ATP), phosphocreatine (PCr) and glycogenic substrates, and the intracellular accumulation of 
metabolites (adenosine di-phosphate (ADP), inorganic phosphate (Pi), hydrogen ions (H+) and 
magnesium (Mg+), each of which has been implicated as a cause of muscle fatigue (Smith et al., 
2009).  Depletion of PCr store has frequently been cited as a rate limiting factor for performance 
of repeated sprint exercises (Bishop, 2004).  Different aerobic and anaerobic training modalities 
have been shown to enhance performance, including 5- to 30-second repeated sprints 
(Burgomaster, 2006 and Creer, 2004). Recent literature has termed this type of training, high-
intensity interval training (HIIT).  HIIT is also known to be a more efficient training strategy for 
individuals who have time constraints and want to see similar outcomes to those who do a 
traditional endurance training protocol.  According to the National Strength and Conditioning 
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Association, HIIT training can provide benefits such as: aerobic and anaerobic fitness, decreased 
blood pressure, cardiovascular health, insulin sensitivity (which helps the exercising muscles 
more readily use glucose for fuel to make energy), lowered cholesterol, lower abdominal fat and 
body weight while maintaining muscle mass.  
Events such as rowing involve both the anaerobic and aerobic energy systems.  Aerobic 
oxidation takes over after about 75 seconds of near maximal efforts and becomes the primary 
energy system used; it also has the greatest potential for improvement with training, about 2-4% 
in well trained athletes (Laursen, 2010) and more in untrained individuals.  Akca and Aras 
(2015) found that competitive rowers had significantly improved rowing performance (peak 
power output, VO2 Peak, and 2,000 meter time to completion) after 4 weeks of high intensity 
interval training or supramaximal interval training. 
The combination of high intensity interval training and beta-alanine supplementation has 
been shown to improve ventilatory threshold (VT), this has been highly correlated with lactate 
threshold (LT).  While these represent different metabolic mechanisms they are both 
representative of anaerobic threshold (AT) (Bishop, 2004).  Anaerobic threshold can be defined 
as the exercise intensity at which performance decrements rapidly ensue and are considered the 
onset of fatigue (Walter, 2010).      
There is a dearth of scientific research that involves recreationally active females, 
especially using the rowing ergometer as a mode, current research uses the cycle ergometer or 
treadmill and to our knowledge there is no current research that specifically looks at BA 
supplementation combined with HIIT using non-competitive female rowers.  Therefore, the main 
purpose of this study was to determine if beta-alanine supplementation combined with four 
weeks of high intensity interval training on the rowing ergometer would lead to significant 
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improvements in oxygen consumption (VO2peak), ventilatory threshold, and body fat percentage 
in recreationally active females. A secondary purpose of this study was to look at time to 
complete a 1,000 meter time trial and peak power output in pre and post testing as well as 
segmental body composition changes in the arms, trunk, and legs.  It was hypothesized that 
supplementing with beta-alanine and HIIT for 28 days would lead to improvements in VO2 peak, 
ventilatory threshold, body composition, 1,000 meter time trial, and peak power. 
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CHAPTER II 
REVIEW OF LITERATURE 
 Most research using the rowing ergometer involves competitive rowers, as this mode can 
provide a full body workout while using both anaerobic and aerobic energy pathways.  High 
intensity interval training (HIIT) has become popular for people who have time constraints, but 
want the benefits of endurance training, improvements in oxygen consumption and time to 
exhaustion (NSCA).  Beta-alanine supplementation has been shown to help with pH buffering in 
skeletal muscle and can attenuate muscular fatigue.  Combinations of HIIT and BA 
supplementation on the rowing ergometer could potentially delay the onset of fatigue, increase 
peak power, increase oxygen consumption, and improve time trial performance, while providing 
a full body workout. 
Beta-alanine and Carnosine  
Carnosine (β-alanyl-L-hisitdine) is a cytoplasmic dipeptide that is synthesized from beta-
alanine and histidine; it is found in the highest concentration in skeletal muscle and relatively 
high concentrations within the central nervous system (Sale, 2013).  Carnosine contributes to 
intracellular muscle pH buffering capacity and among other functions is thought to play a role in 
slowing the development of acidotic muscle fatigue (Decombaz, 2011; Artioli, 2010; and 
Derave, 2007).  Oral ingestion of beta-alanine (3.2-6.4g/day), the rate limiting precursor in 
carnosine synthesis, has been shown to elevate the muscle carnosine content by ~45-60% after 4 
weeks of supplementation with an aim to improve anaerobic muscle capacity and muscle 
function during high intensity exercise (Harris, 2006 and Derave, 2007).  The endogenous 
formation of beta-alanine in humans is synthesized in the liver from degradation of uracil, where 
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exogenous supply mostly depends on the type and amount of animal protein in the diet 
(Decombaz, 2011).  On average an omnivore can ingest ~ 0.8 g/day of carnosine from meat and 
fish (Harris, 2006) with the highest concentrations found in chicken and turkey (Abe, 2000). 
Harris and colleagues (2006) tested three different doses: 40, 20, and 10 mg/per kg of 
body weight/per day.  They found that the highest dose elicited a peak in serum beta-alanine 
levels, which was related to intense and unpleasant symptoms of paresthesia starting 
approximately 20 minutes after the capsule ingestion and ending approximately 60 minutes after.  
Parasthesia is defined as a skin sensation, such as burning, prickling, itching, or tingling, with no 
apparent physical cause and could potentially cause unpleasant sensory symptoms associated 
with the ingestion of beta-alanine.  The 20 mg dose resulted in a lower peak in serum beta-
alanine, but was also accompanied by symptoms of paresthesia, which were less frequent and 
intense, while the 10 mg/per kg of body weight resulted in no significant symptoms of 
paresthesia and a discrete peak of serum beta-alanine.  Harris et al. (2006) split the amounts of 
beta-alanine given daily into multiple doses of 800 mg (~10 mg/kg/day) and was successful in 
reducing the incidence of paresthesia.  Numerous studies have also confirmed the efficacy of this 
supplementation protocol, (Hill, 2007 and Kendrick, 2008), and more recently, data suggest that 
it is possible to reach the same total daily dose of 6.4 g using a twofold higher single dose when 
using controlled release capsules (1600 mg instead of 800 mg) (Hoffman, 2008, Stout, 2007, and 
Zoeller, 2007). 
Decombaz et al. (2011) compared the kinetics of plasma beta-alanine and its association 
with beta-alanine induced paresthesia symptoms following the ingestion of 1.6 g/day of beta-
alanine slow release tablets or the pure aqueous solution of beta-alanine.  Three different 
treatments were administered: 1.6g of pure beta-alanine in an aqueous solution, 1.6 g of slow 
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release beta-alanine, or placebo (Carnosyn™, Natural Alternatives International (NAI), San 
Marcos CA) each was ingested with 250 ml of water.  Each treatment was separated by one week 
and in a fasted state.  Subjects were provided with questionnaires with information on sensations, 
mood, or anxiety state and blood and urine samples were collected at various intervals to assess 
beta-alanine concentrations over the course of the next 6 hours.  Researchers found that ingesting 
slow release tablets, rather than the pure solution, improved retention of carnosine and there was 
no evidence of paresthesia in either group. 
Stegen and colleagues (2014) designed an experiment to determine an optimal 
maintenance dose ensuring that carnosine levels remained elevated by 30-50% above baseline.  
They wanted to determine if sex, body mass, and fat free mass are factors during muscle 
carnosine loading, maintenance, and washout.  The researchers found that sex and body mass 
have minimal effects on absolute carnosine increases and are not the major determinants for 
increases in carnosine content.  In order to keep levels ~30-50% above baseline, an average dose 
of 1.2 g/day is considered optimal to maintain carnosine concentration. The washout period for 
beta-alanine appears to be a relatively slow process ~2-4% a week, but is also related to the 
carnosine content; essentially, the more you have, the more you can lose (Stegen, 2014; Baguet, 
2009; and Stellingwerff, 2011).   Moreover, Baguet and colleagues (2009) showed that there are 
high and low responders to beta-alanine supplementation.   The washout period for high 
responders is about 15 weeks compared to 6 for low responders, this after supplementing with 
4.8 g/day for 6 weeks (Baguet et al., 2009).  Evidence seems to indicate that taking beta-alanine 
is safe is doses from 3.2-6.4 g/day and that the slow release tablets can help reduce the incidence 
of any unpleasant side effects.   
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Beta-alanine and Performance 
Several researchers have used the non-invasive method called proton magnetic resonance 
spectroscopy (MRS) to assess carnosine concentrations in skeletal muscle and have determined 
that it is an effective and practical tool that can be used to assess muscle carnosine content as 
opposed  to muscle biopsies (Bex, 2013 and  Derave, 2007).  Bex and colleagues (2013) also 
wanted to determine if carnosine concentrations were higher in trained rather than untrained 
individuals.  The study found that the carnosine levels were much higher (almost double) after 
supplementation as compared to the untrained individuals (Bex et al, 2013) which is comparable 
to other studies (Baguet et al., 2010; Derave,et al., 2007; and Saunders, 2012).  In contrast 
Painelli and colleagues (2014) found that beta-alanine, when used an ergogenic aid for high- 
intensity exercise, can improve exercise performance regardless of training status.  In a similar 
study Derave and colleagues (2007) aimed to evaluate the use of proton MRS as a non-invasive 
tool to monitor carnosine concentrations and to determine if supplementation with beta-alanine 
for 4 weeks would elevate muscle carnosine and affect exercise performance in 400 m sprint 
among trained athletes.  The beta-alanine group significantly increased carnosine content and 
dynamic knee extension torque significantly improved as compared to the placebo group.  
Despite conflicting results it would appear that in certain situations beta-alanine can augment 
carnosine content in trained individuals more than in the untrained.   
Jordan and colleagues (2010) were the first researchers to look at running performance 
and the onset of blood lactate accumulation (OBLA) during a graded exercise test (GXT) after 
supplementation with beta-alanine.  The beta-alanine group did have a delay in the onset of 
OBLA after 4 weeks of supplementation, but also had a reduced aerobic capacity in comparison 
to the placebo group.  Other research has shown that supplementing with beta-alanine can also 
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reduce the onset of blood lactate accumulation (OBLA) by increases in heart rate at OBLA, % 
heart rate max @ OBLA as compared to the placebo groups (Jordan, 2010 and Zoeller, 2007).  
Both studies also showed no changes in VO2 peak or decrements with the beta-alanine, these 
were similar to other findings (Stout, 2006; Baguet, 2010; and Kresta, 2014).  Other studies have 
shown that supplementing with beta-alanine, sodium bicarbonate, or the combination of the two 
can increase blood lactate levels during exercise (Tobias et al., 2013 and Mero et al., 2013).  
Saunders and colleagues (2012a) found that both the placebo and beta-alanine groups had 
increased blood lactate levels during exercise with no effects from supplementation.  This is 
similar to what Baguet et al. (2010) found in a comparable study. While blood lactate levels 
increase during exercise, the reduction of OBLA improved after supplementing with beta-
alanine, sodium bicarbonate, or the combination of the two.  VO2 peak did not significantly 
improve in the groups, however time to exhaustion did improve. This delayed onset of 
neuromuscular fatigue was most likely due to the increased carnosine concentration.  
Stout et al. (2006) examined the effects of 28 days of beta-alanine supplementation and 
the onset of neuromuscular fatigue and ventilatory threshold among women.  The researchers 
found that the ventilatory threshold (VT) improved, physical working capacity increased, and 
time to exhaustion all improved in the beta-alanine group as compared to the placebo group.  
They did not see any significant improvements in maximal oxygen consumption.  In contrast 
Smith and colleagues (2012) found that both the beta-alanine and placebo groups had significant 
improvements in maximal oxygen consumption and slight, non-significant changes in time to 
exhaustion and ventilatory threshold.  Kresta et al. (2014) researchers had recreationally active 
females supplement with creatine and beta-alanine combined, beta-alanine, creatine, or placebo.  
They found that there were not any significant improvements on body composition, aerobic (VO2 
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peak, TTE, or VT), or anaerobic performance (total work or peak power) measures in any of the 
groups.   
Hoffman and colleagues (2014) wanted to determine if supplementation with beta-alanine 
could improve tactical and cognitive performance among an elite combat unit after a series of 
exhaustive exercises.  The researchers found that cognitive performance was not impacted, but 
power performance, marksmanship, and target engagement speed improved from pre-ingestion 
levels.  Both the placebo and beta-alanine groups had significant improvements in their 4km run 
time, but no difference between groups.  Peak jump power and number of firing shots at post 
testing was greater for the participants who consumed beta-alanine as compared to the placebo 
group.  
Painelli et al. (2014) looked at the effects of training status on high intensity intermittent 
performance after supplementing with beta-alanine.  The trained (T) and non-trained (NT) men 
were split between placebo (PL) and beta-alanine (BA), this provided four experimental 
conditions total.  Researchers found that total work done significantly increased following 
supplementation in both the TBA and NTBA groups, significantly decreased in the NTPL, and 
had no change in the TPL.  Regardless of training status researchers determined that using beta-
alanine as an ergogenic aid for high intensity exercise can be beneficial.  These findings are in 
contrast to previous studies that have shown no effect of beta-alanine supplementation with 
highly trained individuals (Derave et al. 2007; Baguet et al 2010; and Saunders et al 2012). 
Baguet and colleagues (2010) looked at the role of muscle carnosine in rowing 
performance and found that there was a positive correlation between the two.  The beta-alanine 
group also improved time to exhaustion following supplementation by 4.3 seconds as compared 
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to the placebo group.  Ducker et al. (2013) found that 2,000 meter rowing performance did 
improve after 28 days of beta-alanine supplementation in well trained rowers, however this only 
had a significance level of (p < 0.055) and was not supported by moderate to large effect size 
(Ducker, 2013).  While both of these studies showed improvements in performance, it should be 
noted that they both had small sample sizes and both had p- values that were near significance.  
During intense anaerobic exercises, one of the major causes of fatigue is believed to be 
acidosis caused by the accumulation of hydrogen ions [H+], this corresponds to the decrease of 
the pH in blood.  Along with carnosine being used as a pH buffering agent is sodium 
bicarbonate, which can also be used as an ergogenic aid.  Tobias et al. (2013) had well-trained, 
experienced judo and jiu-jitsu male competitors complete the study. They were randomly 
assigned to the placebo (PL+PL), beta-alanine + placebo (BA+PL), placebo + sodium 
bicarbonate (SB+PL), or beta-alanine + sodium bicarbonate (BA+SB) group.  Both BA+PL and 
SB+PL had gains in the total work done, peak power, and post exercise blood lactate.  The group 
that had co-ingestion (BA+SB) had a significant effect on total work done, peak power, post 
exercise blood lactate, and ratings of perceived exertion (RPE).  Researchers concluded that 
while sodium bicarbonate and beta-alanine and can elicit improvements in aerobic and anaerobic 
measures the two combined can significantly lead to greater improvements in performance and 
RPE.  Furthermore, taking the two in combination enhances it’s effects as a buffering agent 
during intense exercise.    
Several studies have also investigated the effects of beta-alanine supplementation on 
body composition (Glenn et al., 2015; Kresta et al., 2014; Kern et al., 2011, and Outlaw et al., 
2014).  Glenn and colleagues (2015) looked at total body fat percentage as well as regional areas 
of interest and found that after supplementing with beta-alanine for 28 days female masters 
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athletes elicited no significant reductions in body fat.  Similarly in another study by Kresta et al. 
(2014) researchers looked at changes in body weight, fat mass, fat free mass, and total body fat 
and found that after supplementing with beta-alanine, creatine, or the combination for 28 days all 
three groups had improvements in body weight and other markers of body composition over 
time, but none were statistically significant.  Kern et al. (2011) had in season wrestlers and 
football players supplement with beta-alanine or placebo for 8 weeks and found that both groups 
had increases in lean body mass.  It should be noted that wrestlers during this phase of training 
are also cutting weight, their losses in fat mass and weight were higher than those of the football 
players who actually gained weight.  While not significant, both groups increased lean mass as 
compared to the placebo groups.  Outlaw and colleagues (2012) found that after 8 weeks of both 
supplementing with beta-alanine or placebo and undergoing a resistance training program that 
both groups elicited improvements in lean body mass, fat mass, and total body fat %.  While all 
of these groups showed improvements or changes over time not all of them were statistically 
significant and because most were already trained or were doing some sort of intervention we 
cannot be sure that it was because of beta-alanine or the combination of exercise and BA 
supplementation. 
HIIT 
Recurring bouts of very intense exercise with breaks that vary in length are referred to as sprint 
interval training or high intensity interval training (HIIT).  The physiological adaptations to this 
type of training are similar to those of a more traditional endurance training protocol (longer 
steady state exercise) and provide benefits such as: cardiopulmonary, metabolic, and 
neuromuscular adaptations (National Strength & Conditioning Association, 2016).  Moreover, 
this type of workout is often appealing to individuals with time constraints, but is at a very high 
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intensity and thus not appropriate for an untrained individual because of the dangers associated 
with high intensities.  In addition, the intensities and durations for work to rest ratios are 
important factors to consider when dealing with different populations.  In a review article, 
Laursen et al. (2010) discusses the energy contributions made from both the anaerobic and 
aerobic systems and how HIIT and high volume training can both elicit improvements in 
exercise performance and should both be utilized.  Bishop et al. (2004) investigated the 
relationship between muscle buffer capacity and repeated sprint ability (RSA) among untrained 
females. Results showed that VO2 peak and lactate threshold are significant predictors of RSA 
and the ability to buffer H+ is important when one is trying to maintain performance during 
repeated sprints.  While this study did not implement a HIIT intervention, it did provide evidence 
that training status and aerobic capacity of an individual can affect their ability to perform 
repeated sprints.  HIIT can provide anaerobic and aerobic enhancements, similar to a more 
traditional endurance training program.  Furthermore, it can increase muscle buffering capacity. 
 Burgomaster et al. (2005) aimed to examine the effects of short term (2 weeks) sprint-
interval training (SIT) on endurance capacity at 80% of VO2 peak, maximal oxygen uptake, and 
endurance time to exhaustion cycling.  Results showed that there were no changes in VO2 peak, 
but that aerobic endurance capacity improved by almost 100% in the SIT group as compared to 
the control group.  In another study done by Burgomaster and colleagues (2006), researchers 
found similar results: there were no changes in VO2 peak, time trial cycling improved by ~10% 
in the intervention group while also showing an increase in peak power output.  This is in 
contrast to what Talanian and colleagues (2006) found.  Their study aimed to determine if two 
weeks of high-intensity interval training (HIIT) had an effect on skeletal muscle metabolism, 
aerobic capacity, and fat oxidation. Results showed that VO2 peak increased by 13% and whole 
20 
 
body fat oxidation increased by 36%. Overall, even over a short period of time HIIT could 
induce marked increases in time trial performance, VO2 peak, and endurance capacity. 
 Esfarjani and Laursen (2007) examined the difference between two different HIIT 
protocols over 10 weeks on VO2 max, lactate threshold and 3,000 meter running performance.  
Both groups had significant improvements in 3,000 meter run time, VO2 max, and lactate 
threshold as compared to the control group.   
 Acka and Aras (2015) looked at differences between HIIT and supramaximal interval 
training (SMIT) over 4 weeks on indoor rowing performance.  The HIIT group was working at 
90% of their PPO while the SMIT was working at 150% during each session.  Both groups, 
while not significantly different improved 2,000 meter rowing time, peak power output, and VO2 
peak.  These are similar findings to those of Driller et al. (2009) who also looked at the effects of 
HIIT in well trained rowers.  The HIIT group had significant improvements in 2,000 m time, 
peak power, and relative VO2 peak.  Both of these studies show that even well trained rowers can 
benefit from HIIT at varying high intensities and that it can be especially beneficial when 
training for a 2,000 m race when you need the last bout of energy to finish strong. 
Beta-alanine and HIIT 
 High-intensity exercise can result in diminished stores of the adenosine tri-phosphate 
(ATP), phosphocreatine (PCr) and glycogenic substrates, and the accumulation of intracellular 
metabolites (adenosine di-phosphate[ADP], inorganic phosphate [Pi], hydrogen ions [H+] and 
magnesium [Mg+]), each of which has been implicated as a cause of muscular fatigue (Smith et 
al., 2009).  As mentioned previously the formation of H+ can result in a decrease in pH, most of 
these protons that are formed during exercise are buffered by the sodium bicarbonate system 
(HCO3
-).  However, during short bursts of intense exercise, such as HIIT, the physiochemical 
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buffering will exceed what the HCO3
 – system and use other intramuscular stores of phosphates 
and peptides.  Carnosine concentration is high in skeletal muscle and its pKa of 6.83 make it 
more effective at sequestering protons than either HCO3
 –  (pKa 6.73) or Pi (pKa 7.2), this is 
limited by the availability of beta-alanine.   Smith and colleagues (2009) conducted a study to 
evaluate the effects of beta-alanine supplementation combined with high-intensity interval 
training (HIIT) on endurance performance and aerobic metabolism in recreationally active 
college-aged men.  Forty-six men were randomly assigned to either the placebo or beta-alanine 
group and were tested for VO2 peak, time to exhaustion (TTE), ventilatory threshold (VT), and 
total work done (TWD) at 110% of pre-training VO2 peak.  The beta-alanine group showed 
significant improvements in VO2 peak, TTE, and TWD after the first three weeks of training.  
Supplementing with beta-alanine may further enhance HIIT, improve endurance capacity, and 
lean body mass in recreationally active men along with the use of HIIT to induce aerobic 
improvements. 
Saunders and colleagues (2012b) had amateur male footballers supplement with either 
beta-alanine or placebo for 12 weeks and were asked to perform the YoYo Intermittent Recovery 
Test 2 (IR2) prior to supplementation and again after 12 weeks of supplementation.  This test 
evaluates an individual’s capacity to perform high-intensity exercise while simultaneously 
stimulating both aerobic and anaerobic energy pathways (Saunders, 2012b).  Researchers found 
that the distance covered by the beta-alanine group was significantly higher than the placebo 
group after 12 weeks of supplementation, delaying neuromuscular fatigue, most likely due to 
increased carnosine content.  In another study by Kern et al (2011) football players and wrestlers 
were randomized and placed into either a placebo or beta-alanine group for 8 weeks.  All players 
maintained regular team workout, similar to a periodized HIIT program.  The football players 
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showed greater improvements than the wrestlers in a 300 yard shuttle run and a 90º flexed arm 
hang, while neither were statistically significant both improved with the groups who 
supplemented with beta-alanine as to the placebo group.   
Walter and colleagues (2010) looked at cardiovascular fitness and body composition 
changes among women after supplementing with placebo or beta-alanine for 8 weeks.  Both 
groups underwent a rigorous periodized HIIT protocol on the cycle ergometer 3 times a week for 
8 weeks.  Both the placebo and beta-alanine groups showed improvements in VO2 peak as 
compared to the control group, ventilatory threshold improved in all 3 groups, but no 
improvements other than body mass increases for all groups occurred over 8 weeks.  This is 
similar to what Smith et al. (2009b) found after having men supplement with beta-alanine or 
placebo for 6 weeks.  There were significant changes in VO2 peak, time to exhaustion, and total 
work done in both groups, while the group that supplemented with beta-alanine had greater 
improvements in all three during the second three weeks of training.  There were also significant 
improvements with ventilatory threshold, but the placebo group had larger improvements during 
the second half of the study.  The beta-alanine group also showed gains in lean body mass, which 
is similar to what Kerns et al. (2011) found.   
In another study done by Smith and colleagues (2009a), neuromuscular fatigue and 
muscle function among men after supplementing with beta-alanine or placebo combined with 
HIIT over 6 weeks was observed.  The researchers in this study used an EMG to identify 
neuromuscular fatigue by looking for increases in amplitude.  Both groups’ significantly 
increased neuromuscular fatigue and physiological functioning of lower body muscle tissue, it 
would appear that supplementing with beta-alanine had no impact and most positive results were 
due to the HIIT.  Similarly Stout and colleagues (2007) measured physical working capacity at 
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fatigue threshold and saw significant improvements in neuromuscular fatigue, but no HIIT was 
prescribed.  While both delayed the onset of neuromuscular fatigue their findings show that one 
is because of HIIT and the other because of beta-alanine supplementation.  Despite the 
conflicting results from both studies, it could be due to the methodological differences, or sample 
size. 
The potential ergogenic effects of beta-alanine supplementation, across a wide range of 
exercises, has been shown to delay the onset of neuromuscular fatigue, and improve PPO or 
TWD, while HIIT seems to have more effects on maximal oxygen uptake and buffering capacity.  
Moreover, when combined BA has been shown to enhance HIIT, improve time to exhaustion and 
in some cases stimulate lean body mass. 
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CHAPTER III  
METHODOLOGY 
 
Participants 
Thirty four females between the ages of 18-35 from Georgia Southern University were 
recruited to participate in the study (Mean ± SD for age, height [cm], and weight [kg] are 
reported in (Table 1). The requirements were that each woman was moderately active (~150 
minutes/weekly as recommended by American College of Sports Medicine).  Participants who 
were currently or had taken any sort of ergogenic supplement (i.e. creatine or beta-alanine) in the 
last 12 weeks were excluded from the study.  This was a randomized, double-blind, placebo-
controlled study and participants were randomly placed in either the control group (C), the 
placebo group (PLA), or the Beta-alanine group (BA).  The BA and PLA were labeled (A or B) 
and placed in identical containers by the company (Carnosyn® Natural Alternatives International 
(NAI), San Marcos, CA, USA) so that the researchers and participants could not tell the 
difference.  Participants were then matched with two other females based off of height, weight, 
and self-reported hours of physical activity weekly and then randomly placed in either group A, 
B, or C so that there was an equal distribution and matched participants throughout the groups.  
The CON group underwent the pre and post testing procedures only, while the PLA and BA 
groups did the pre and post testing procedures, and a 4 week HIIT intervention on the rowing 
ergometer.  The participants were given an explanation of the procedures, risks, possible benefits 
from the intervention and/or supplement, and then gave informed consent to participate in the 
study. The Institutional Review Board of Georgia Southern University approved this study.  
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Familiarization 
This was done during the first week of the study and participants were randomly assigned 
to the BA, PLA, or CON groups these were labeled as A, B, and C respectively.  Participants 
were then asked to sign the informed consent, and go over testing protocols as well as rowing 
technique.  Participants were asked to fill out a Par-Q+ health questionnaire before any testing 
takes place, those not contraindicated by Par-Q+ could safely engage in VO2max testing and high 
intensity interval training.  The participants were then asked to watch a short video 
demonstrating proper rowing technique (concept2.com/technique) to help reduce injury and 
increase efficiency on the rowing ergometer.  During the familiarization period participants also 
demonstrated to researchers that they were using proper techniques and had proper foot 
placement on the rowing ergometer.   Foot placement and attachment was important for optimal 
performance and the heels were positioned in the foot stretcher so that the strap crossed over the 
ball of participant’s foot, this was consistent throughout all testing procedures on the rowing 
ergometer.   While there are two parts to the rowing stroke, the drive and the recovery, it is all 
done in one continuous motion.  Participants extended arms forward, body leaning towards the 
flywheel, and knees bent, this was the catch.  The drive began with participants straightening 
their legs, which did the majority of the work while keeping their arms and shoulders relaxed.  
After the legs were fully extended the rower used their core and back to swing back to the 
vertical position.  During the last part of the drive the participant pulled the handle of the rowing 
ergometer with their arms and shoulders into the abdomen, the legs were straight and the body 
was leaning slightly back.   The recovery began by extending the arms forward and swinging the 
body forward at the hips, this put the handle back in front of the knees to avoid any interference 
between the knees and the hands as the seat moved forward.  The last motion, the catch, is the 
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exact same as the start position and the participants could begin their next drive in one 
continuous motion.  Participants were reminded that their body should never come to a complete 
stop (Concept II Product Manual).  Once the participants felt comfortable with the equipment 
and protocols they began pre-testing procedures. 
Pre and Post Testing 
All three groups underwent all pre-testing protocols: anthropometric measurements, body 
composition on the dual energy x-ray absorptiometry (DEXA) scanner, a VO2 max test on a 
Concept II Rowing Ergometer (Model E, Type II, Concept2 Inc., Morrisville, VT, USA) and a 
1,000 meter time trial.  The three groups of women all came to the Human Performance Lab 
during week 2 for all pre testing and during week 7 for post testing procedures.  The first day 
included anthropometric measurements, DEXA scan, and VO2 max testing and no less than 48 
hours later they came back to the lab to complete the 1,000 m time trial on the rowing ergometer.  
Participants were also asked to keep a food log using My Fitness Pal (MyFitnessPal, Inc.) for 
two weekdays and one weekend and to share the information with the researchers to keep track 
of macronutrients in the diet.  On testing days, participants were also asked to consume a diet 
that was similar or the same to be consistent and to maintain their normal dietary and physical 
activity routines throughout the duration of the study.  Participants came to the lab for their first 
day of actual testing wearing athletic attire.  Their mass (kg) and height were measured (cm) 
using a stadiometer, waist and hips (cm) were measured with a spring loaded Gulick Measuring 
Tape (Country Technology, Inc., Gays Mills, WI,USA) and were done prior to the DEXA scan 
and exercise.  
 Participants then had a whole body scan done using (DEXA) to determine body 
composition.  All scans were performed and analyzed by a trained technician using the AIS 
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whole-body DEXA protocol (Nana et al., 2012).  Prior to testing the DEXA Scanner (Lunar 
Prodigy Model; GE/Lunar Corp,  Madison, WI, USA) was calibrated per manufacturers 
guidelines using the GE Encore 12.30 Software and phantom.  Participants were instructed to 
wear metal free clothing and to remove all jewelry and other metal before the scan.  Each 
individual was centrally positioned on the scanner and feet were strapped together to maintain a 
constant distance (~15 cm), hands were placed at the sides within the given parameters.  The 
scan took about 6-8 minutes and the whole body scan mode was used.  Researchers looked at 
regional body fat % for both arms, legs, and trunk researchers had to manually adjust the regions 
of interest (ROI).  Stults-Kolehmainen et al. (2013) defined the regions of interest using the 
following for parameters.  The arm region was comprised of the arm and shoulder area formed 
by placing a line from the crease of the axilla and through the glenohumeral joint.  The trunk 
region included the neck, chest, abdominal and pelvic areas.  Its upper perimeter is the inferior 
edge of the chin and the lower borders intersect the middle of the femoral necks without touching 
the brim of the pelvis.  The leg region included all of the area below the lines that formed the 
lower borders of the trunk (Stults-Kolehmainen et al., 2013). 
 TheVO2max testing protocol was completed on the rowing ergometer using the 
ParvoMedics Metabolic cart (True One 2400, Sandy, UT, USA).  Prior to testing the metabolic 
cart was calibrated per manufacturer’s guidelines, this included the gas and flowmeter calibration 
protocols.   Participants were then setup on the rowing ergometer (Model E, Concept2 Inc., 
Morrisville, VT, USA) and a heart rate monitoring strap was placed across the chest (Garmin 
Model FR70, Olathe, KS, USA).  The drag factor was set at 3 for all testing and intervention 
days.  The test began at an initial workload of 75 W for two minutes, and was then increased to 
100 W for a further two minutes.  The workload was then increased an additional 25 W every 
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two minutes until the participant could no longer continue, despite verbal encouragement.  If the 
participants could not maintain appropriate Watts (within 15 above or below), or any 
contraindications to testing arose, the test was terminated.  All data was averaged over 15-s 
intervals and the highest 15-s VO2 value during the graded exercise test was recorded as VO2peak , 
if it coincided with at least two of the following criteria: (a) a plateau in heart rate or heart rate 
values within 10% of the age-predicted maximum heart rate, (b) a plateau in VO2 (defined by an 
increase of no more than 150mL/min (Thompson et al., 2010) or the respiratory exchange ratio 
has exceeded (RER > 1.15).  The ventilatory threshold (VT) inflection point was determined by 
the True One program using the V-slope method. This eliminated the need for multiple 
researchers to evaluate and confirm inflection points.   Maximal oxygen uptake (VO2peak) in 
(L/min and ml/kg/min), power output at the ventilatory threshold (VT), time-to-exhaustion 
(TTE), maximal heart rate, ratings of perceived exertion (RPE), using a 6-20 numeric scale 
(Borg, 1970) were measured and recorded. 
 Within 48-72 hours of maximal testing participants came back to the Human 
Performance Lab to complete an all-out 1,000 m time trial (TT) on the rowing ergometer.  
Participants were set up on the Type II Concept Rower in the same fashion that they were on day 
1 of pre-testing and a heart rate strap (Garmin Model FR70, Olathe, KS, USA or Polar) was 
placed across the chest to monitor heart rate.  Participants were allowed to warm up for 3-5 
minutes at a low intensity before the TT and also allowed a cool down after the TT on the rowing 
ergometer or treadmill.  The distance was programmed into the PM4 monitor and display so that 
the participant and researcher could see total distance covered, time, heart rate, average watts, 
and peak power; these values were all recorded.  Participants were informed to row “all out” and 
told to not stop, encouragement was given throughout the test. 
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Beta-alanine and Placebo Dosing 
 After being randomly assigned to either the beta-alanine (BA) or placebo (PLA) group, 
which were called A and B respectively, participants were given weekly doses (56 pills) of 
supplement or placebo in identical white bottles labeled A or B.  Both groups took either 6.4 
grams of maltodextrin or beta-alanine daily, these were the time-released capsules that were pre-
packaged and blinded by the company Carnosyn® (Natural Alternatives International, San 
Marcos, CA, USA).  Each participant took 2 pills four times daily (8 pills total) for 28 days, they 
were given a log to keep track of times and doses on a weekly basis to ensure compliance.  On 
training days the participants were asked to consume one dose of their supplement or placebo 30 
minutes prior to training and another immediately following.  It was expected to observe an 
increase in muscle carnosine content to be close to 15 mmol/kg dry muscle (an increase of 65% 
in a participant eating a mixed diet), given that Harris et al. (2006) reported this level of increase 
following a similar but slightly lower total dose of beta-alanine. 
High Intensity Interval Training Protocol 
 During the next four weeks the PLA and BA groups met with a researcher to begin the 
high intensity interval training intervention.   Participants came to the Human Performance Lab 
three times weekly on nonconsecutive days.  Each session lasted around 15 minutes, participants 
were asked to maintain a regular workout regimen during the week, but to refrain from workouts 
on intervention days.  These included a warm up and cool down on the rowing ergometer.  
During the intervention portion of the study, PLA and BA groups were given training and 
supplement logs to document their type, intensity, and duration of workouts along with their 
dosing logs to ensure compliance. The intensities were undulating (Figure 1) and were based off 
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of a similar protocol that Walter et al. (2012) did in their study on a similar population of 
females.  Thirty minutes prior to arriving, participants were asked to take two 800 mg capsules of 
placebo or beta-alanine and take a second dose immediately following the training session.  
Participants were setup on the rowing ergometer in the same fashion that they were in the 
fatiguing and TT protocol; heart rate was monitored using a Garmin strap attached at the chest 
(Garmin Model FR70, Olathe, KS, USA).  The workout included a 5 minute warm-up and cool 
down that was on the rowing ergometer.  Participants warmed up at 75 W for 5 minutes followed 
by 7 sets of 1-minute exercise bouts at a predetermined percentage of their peak workload using 
a fractal periodization scheme (Walter et al., 2010).   Peak workload was determined during the 
TT testing and was reported as peak power output (PPO), this varied between participants and 
was what determined their workload during training days.  On all odd days (1, 3, 5, 7, 9, and 11) 
participants rowed at a workload that was 90% of their predetermined PPO and on the even days 
(2, 4, 6, 8, 10, and 12) the workload increased by 5% (95%, 100%, 105%, 110%, 110%, and 
115%).  Training volume (seconds completed at each interval), average Watts, heart rate, and 
RPE were recorded.  One minute of passive recovery was allowed between each set.  At the end 
of the 4 weeks, participants discontinued the placebo or beta-alanine supplementation and 
followed up the next week for post testing procedures.  Post–testing procedures followed the 
exact same setup as the pre-testing procedures.  The CON group also reported back to the lab for 
post testing procedures.   
Statistical Analyses 
Eight separate 2 (time) [pre vs. post] ×3 (treatment) [BA vs. PLA vs. CON] repeated mixed 
factorial analyses of variance (ANOVAs) were used to evaluate the following variables: relative 
VO2 peak (ml/kg/min), ventilatory threshold (VT), time to complete 1,000 m time trial (TT), 
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peak power output (PPO), total body fat percentage (BF %), body fat of arms (ABF %), body fat 
of legs (LBF %), and trunk body fat (TBF %).  Further one-way ANOVA’s were run when there 
was a significant interaction between groups and time.  The alpha level was set at p ≤ 0.05 to 
determine statistical significance and a Bonferroni correction was applied.  Data was analyzed 
using SPSS for Windows version 21 (SPSS Inc., Chicago, IL, USA).  All values are reported as 
mean ± standard deviation (SD). 
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CHAPTER IV 
 RESULTS 
Subject Characteristics 
A total of 21 of the 34 woman completed the entire study (BA = 8, PLA = 7, and CON = 6), five 
dropped out due to injuries unrelated to the study, one became pregnant, and seven just did not 
complete the study due to time constraints.  The mean ± SD age for all participants (n = 21) was 
22.2 ± 2.20, body mass 63.00 ± 8.52 (kg), and height 163.59 ± 6.69 (cm), and further subject 
characteristics are shown in (Table 1). 
Relative VO2 Peak (ml/kg/min) 
Relative VO2 peak scores are shown in (Table 2).  There was a main effect of time F (1, 18) = 
15.07, p = 0.01, 2 = 0.46; the mean ± SD for all 3 groups was (35.84 ± 4.12 v. 39.24 ± 5.26) pre 
and post testing.  There was no significant interaction between groups and time F (2, 18) = 3.16, 
p = 0.06, 2 =0.26 however it should be noted that the observed power was 0.53.  There was no 
difference between groups F (2, 18) = 0.77, p = 0.48. 
Absolute VO2 Peak (l/min) 
There was a main effect for time F (1, 18) = 22.60, p = 0.00, 2 =0.56; the mean ± SD for all 3 
groups was (2.25 ± 0.39 v. 2.44 ± .045) pre and post testing.  There was a significant interaction 
by group and time F (2, 18) = 3.76, p = 0.04, 2 =0.30, further one way ANOVA’s were run on 
all groups for the pre and post testing values.  Post hoc analysis for pre testing values showed 
nothing significant F (2, 18) = 1.42, p = 0.27.  Further analysis for post testing values between 
groups also showed no significance F (2, 18) = 2.74, p = 0.09.  
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Time to Exhaustion TTE (seconds) 
Time to exhaustion scores are shown in (Table 2).  There was a main effect for time F (1, 18) = 
13.15, p = 0.00, 2 =0.42; the mean ± SD for all 3 groups was (468.38 ± 98.34 v. 524.67 ± 
99.89) pre and post testing.  There were significant interactions by group and time F (2, 18) = 
6.10, p = 0.01, 2 =0.40, observed power was 0.83, further ANOVA’s were run for the pre and 
post testing values.  Post hoc results for the pre testing values were not significant F (2, 18) = 
0.55, p = 0.59.  Further analysis for post testing values were also not significant F (2, 18) = 1.61, 
p = 0.23. 
Ventilatory Threshold % of VO2 Peak (VT)  
Ventilatory threshold % data is shown in (Table 2).  There was a main effect of time F (1, 18) = 
6.01, p = 0.03, 2 =0.23; the mean ± SD for all 3 groups was (53.38 ± 11.46 v. 63.95 ± 7.26).  
There were no significant interactions between groups and time F (2, 18) = 0.12, p = 0.74, 2
=0.03.  There was also no significance between groups F (2, 18) = 0.14, p = 0.35. 
Ventilatory Threshold (l/min)  
There was a main effect of time F (1, 18) = 6.01, p = 0.03, 2 =0.25; the mean ± SD for all 3 
groups was (1.34 ± 0.31 v. 1.54 ± 0.25 l/min).  There were no significant interactions between 
groups and time F (2, 18) = 0.12, p = 0.89, 2 =0.01 There was also no significance between 
groups F (2, 18) = 1.11, p = 0.11, 2 =0.11. 
Time Trial (TT) 
Time trial data is shown in (Table 2).  There was a main effect of time F (1. 18) = 27.38, p = 
0.00, 2 =0.60; the mean ± SD for all groups was (266.71 ± 19.08 v. 261.83 ± 14.55) seconds.  
There was an interaction between groups and time F (2, 18) = 5.17, p = 0.02, 2 =0.37, observed 
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power = 0.76, further one-way ANOVA’s were run for the pre and post testing values.  Post hoc 
results showed that there was not significance between groups in the pre-testing F (2, 18) = 0.65, 
p = 0.53.  Further analysis between the groups for the post testing showed no significance F (2, 
18) = 0.85, p = 0.44.  
Peak Power Output (PPO) 
PPO data is shown in (Table 2).  There was a main effect of time F (1, 18) = 60.65, p = 0.00, 2
=0.77; the mean ± SD for all groups was (244.86 ± 42.15 v. 322.81 ± 68.21 W) measured in 
Watts.  There was an interaction between groups and time F (2, 18) = 14.07, p = 0.00, 2 =0.61, 
observed power = 0.10, further one-way ANOVA’s were run on the pre and post testing values.  
The pre-testing post hoc showed no statistical significance between groups F (2, 18) = 0.05, p = 
0.95.  Post testing results (Figure 2) revealed significance between groups BA (325.13 ± 22.611 
W) and CON (254.00 ± 40.60 W) groups, p = 0.05 and PLA (378.71 ± 72.23 W) and CON 
groups, p = 0.00.  
Total Body Fat % (BF) 
Total body fat % scores are shown in (Table 3).  There was no main effect of time F (1, 18) = 
2.64, p = 0.12, 2 =0.13; the mean ± SD for all groups was (31.10 ± 5.71 v. 30.71 5.50) percent 
body fat.  There were significant interactions between groups over time F (2, 18) = 4.71, p = 
0.02, 2 =0.34, observed power = 0.72.  Further one-way ANOVA’s were run on pre and post 
testing values.  The post hoc testing for the pre testing values did not show any significance F (2, 
18) = 0.91, p = 0.42.  The post testing values also showed no significance F (2, 18) = 1.26, p = 
0.31. 
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Body Fat % of Arms (ABF) 
Arm body fat % scores are shown in (Table 3).  There was a main effect of time F (1, 18) = 
10.42, p = 0.01, 2 =0.37; the mean ± SD for all groups was (27.07 ± 5.95 v. 25.95 ± 5.86) 
percent body fat in the arms.  There were no significant interactions between groups over time F 
(2, 18) = 1.98, p = 0.17, 2 =0.18.  There was also no significance between subjects F (2, 18) = 
1.40, p = 0.27. 
Body Fat % of Legs (LBF) 
Leg body fat % scores are shown in (Table 3).  There was no main effect of time F (1, 18) = 
0.60, p = 0.45, 2 =0.03.  There was a significant interaction over time between groups F (2, 18) 
= 3.75, p = 0.04, 2 =0.30, observed power = 0.61.  Further one way ANOVA’s were run on the 
pre and post testing values. The pre testing values showed no significance between groups F (2, 
18) = 0.77, p = 0.48.  The post testing values also showed no significance F (2, 18) = 1.05, p = 
0.37. 
Body Fat % of Trunk (TBF) 
Trunk body fat % scores are shown in (Table 3).  There was no main effect of time F (1, 18) = 
2.28, p = 0.15, 2 =0.11.  There was a significant interaction between groups F (2, 18) = 5.28, p 
= 0.01, 2 =0.42, observed power = 0.85.  Further post hoc analysis for the pre testing values 
showed no statistical significance F (2, 18) = 1.13, p = 0.35.  Further post hoc testing also did not 
show any significance F (2, 18) = 1.68, p = 0.21 in the post testing results. 
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CHAPTER V  
DISCUSSION 
 The purpose of this study was to determine if supplementing with beta-alanine combined 
with four weeks of high intensity interval training on the rowing ergometer would elicit 
improvements in VO2 peak, ventilatory threshold, peak power output, and body composition.   
The secondary purpose was to look at time to complete a 1,000 meter rowing time trial and 
changes in regional body fat.  While there is a growing body of evidence that indicates positive 
effects of beta-alanine supplementation on performance measures, several studies have found no 
notable impact.  This study suggests, however, that supplementation with beta-alanine combined 
with HIIT can attenuate fatigue and increase peak power output during time trial performance.  
The main finding of this study indicates that over time both the placebo and beta-alanine groups 
showed improvements in VO2 peak, time to exhaustion, ventilatory threshold, peak power 
output, and reduced arm body fat percentage.  The most noteworthy finding was that the placebo 
and beta-alanine groups had significant improvements in peak power post testing compared with 
the control group.  This was the only variable measured that revealed any changes between 
groups and was likely due to the HIIT intervention. 
 VO2 peak in both the BA and PLA groups improved over time as compared to the CON 
group, however there was no significant difference between those two groups.  These results are 
comparable with what several other studies found (Smith et al., 2012; Smith et al.2009b; 
Walteret et al., 2010), all of which saw improvements in VO2 peak and TTE.  Both Walter et al. 
(2010) and Smith et al. (2009b) implemented a HIIT protocol for six weeks combined with the 
beta-alanine supplementation.  In contrast, a number of other studies have found that 
supplementing with beta-alanine (or combining another nutritional supplement, e.g. creatine or 
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sodium bicarbonate) and/or implementing HIIT has not shown improvements in VO2 peak or 
TTE (Jordan et al., 2010; Zoeller et el., 2007; Outlaw et el., 2014; Baguet et el., 2010b, Stout et 
el., 2006).  Jordan et al. (2010) showed decrements in maximal oxygen uptake, but delays in the 
onset of  blood lactate accumulation (OBLA) in the BA group, which could suggest that 
increases in carnosine can attenuate fatigue.  Similarly, Zoeller and colleagues (2007) noted 
increases in power output at lactate threshold, while the VO2 remained unchanged; neither of 
these studies had an exercise intervention along with supplementation. Outlaw et al. (2014) 
looked at the combination of resistance training and beta-alanine supplementation over 8 weeks 
and showed no improvements in VO2 peak or TTE, but the researchers did suggest that it might 
lead to increased muscular endurance. Moreover, several studies have found aerobic and 
anaerobic benefits after short and long term HIIT (Driller et al., 2009; Acka and Aras, 2015; 
Esfarjani et al., 2006).  Both Acka and Aras (2015) and Driller et al. (2009) looked at varying 
intensities of high intensity training among elite rowers as compared to a more conventional 
rowing training regimen and found that all groups improved VO2 as compared to control group.   
 The results of our study showed VO2 peak improvements in both the BA and PLA groups 
over time as compared to the CON group, commensurate with what other researchers found 
using similar protocols.  In reviewing the literature it should be noted that the studies that did see 
improvements in aerobic capacity typically used a HIIT protocol, while BA supplementation 
alone did not substantiate any improvements in VO2 peak.  Therefore, we can postulate that the 
improvements seen were most likely due to the HIIT protocol and training adaptations that 
occurred on the rowing ergometer and not from BA supplementation.  In addition, our data 
showed that both the BA and PLA groups improved VT as % of VO2 and VT (l/min) over time, 
but there were no differences between groups.  These results support what other studies found 
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(Stout et al., 2006; Zoeller et al., 2007; Walter et al., 2010).  Stout et al. (2006) indicated that 
supplementing with beta-alanine can elicit improvements in VT (l/min) and physical working 
capacity at fatigue threshold (PWCFT), therefore delaying neuromuscular fatigue.  Some studies 
have looked at BA supplementation combined with HIIT and found improvements in VT, total 
work done (TWD), and power output at VT (Smith et al., 2009b; Walter et al., 2010).  In contrast 
Smith and colleagues (2012) found no differences in ventilatory threshold over time or between 
groups who supplemented with BA or PLA and did not receive any sort of exercise intervention.  
The improvements of VT, PWCFT, and TTE might have been due to increases in carnosine 
concentration through beta-alanine supplementation.  These results might suggest that 
supplementing with beta-alanine can help maintain intramuscular pH during intense exercises 
when accumulation of H+ ions is high and delay the onset of neuromuscular fatigue.  These 
muscle carnosine increases must be assumed because carnosine was not directly measured in the 
current study. 
 Participants were asked to do an all-out 1,000 m row during the pre and post testing to 
determine total time and peak power output.  While there were no changes over time in any of 
the groups for completion time there were for peak power out (PPO).  There were also 
differences between groups for TT and PPO.  While further testing between groups during pre 
and post testing for TT did not reveal any significant differences, our data supports the 
hypothesis that both the BA and PLA groups would significantly improve their PPO as compared 
to the CON group.  However, another hypothesis was that the BA group would be significantly 
higher than the PLA group, yet there were no differences.  There have been a few studies that 
have examined 2,000 m time trial performance among elite rowers (Ducker et al., 2013; Baguet, 
2010) while supplementing with beta-alanine and maintaining their typical training.  Both studies 
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found no significant improvements in TT performance after supplementation with BA; however, 
it should be noted that while these were not significant there were reductions in overall time to 
complete a 2,000 m TT.  In a competition setting this would be considered a considerable 
difference.  This was similar to what Kern and Robinson (2011) found among football players in 
season; their 300 m shuttle time improved (1.1 seconds) after supplementing with BA as 
compared to PLA group (0.4 seconds).  While Ducker et al. (2013) did not see improvements in 
TT after 28 days of beta-alanine supplementation split times and average power did increase in 
the BA group as compared to the PLA group.  In a comparable study Baguet and colleagues 
(2010) determined that there was a positive correlation between increased carnosine content and 
rowing performance.  Similarly Saunders et al. (2012a) and Derave et al. (2007) found no 
improvements in performance after supplementing with beta-alanine.  While these studies had 
methodological differences and did not look at a time trial specifically they did look at distance 
covered during LIST (repeated sprints) and time to complete a 400 m run respectively.  In 
contrast Saunders and colleagues (2012b) found that football players (soccer) significantly 
increased distance covered during the anaerobic YoYo IR2 (see definition) after supplementing 
with BA for 12 weeks.   
 There are a multitude of studies using a variety of modes that found improvements in 
time trial performance after implementing a HIIT program anywhere from 2-8 weeks long with 
varying degrees of intensities (Acka and Aras, 2015; Driller et al., 2009; Burgomaster et al., 
2005; Esfarjani et al., 2007).  Driller et al. (2009) and Acka and Aras (2015) both looked at 
performance among elite rowers after having groups either use a more conventional training 
method for rowing or HIIT; both groups 2,000 m time and average power significantly improved 
during the TT.  Burgomaster et al. (2005) and Esfarjani et al. (2007) used the cycle ergometer 
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and running respectively and implemented varying intensities for the HIIT protocol; both saw 
significant improvements in time.  In a meta-analysis, Hobson et al. (2012) concluded that BA 
was effective in improving high intensity exercise in durations between 60-240 seconds and in 
excess of 240 seconds and that the anaerobic energy system contributed significantly.  The 
current study might not have had a large enough sample to determine if the BA was as much of a 
contribution to performance enhancements as the HIIT. 
 Results indicated that PPO improved over time and that there were significant differences 
between the BA and CON and the PLA and CON.  In addition, it appears that the increases in 
PPO were due more to the HIIT rather than the combination of HIIT and BA supplementation 
which could also be a reflection of low sample size.  Several other studies have shown that beta-
alanine supplementation alone can elicit improvements in PPO (Tobias et al., 2013; Ducker et 
al., 2013; Van Thienen et al., 2009; Painelli et el., 2014).  Researchers that implemented HIIT on 
a variety of modes supported these findings (Acka and Aras, 2015; Driller et al., 2015; 
Burgomaster et al., 2005).  Smith and colleagues (2009b) found that TWD improved after 
supplementing with BA combined with HIIT over 6 weeks.  In contrast the study by Outlaw et 
al. (2014) did not show any significant improvements in PPO after 8 weeks of BA 
supplementation combined with a resistance training program.  Other studies suggest that the 
combination of BA and HIIT can further delay time to exhaustion and improve TWD or PPO.  
One can speculate that the current study might have found differences between the BA and PLA 
groups had more women been recruited and perhaps matched based on VO2 peak or PPO from 
the initial pre-testing procedures.   
 This study did not show any significant differences in total BF%, leg BF%, or trunk BF% 
over time or between groups.  While most studies using DEXA looked only at total body fat 
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percentage (BF%), lean body mass, and fat mass, our study assessed all of these as well as 
regional areas of interest (arms, legs, and trunk), similar to (Glenn et al., 2015), which showed 
comparable results to the current study.  A number of other studies have looked at the ergogenic 
effects of beta-alanine supplementation on body composition and found similar results (Kresta et 
al., 2014; Kern et al., 2011; Outlaw et al., 2014; Walter et al., 2010).  While these studies had 
methodological differences they all indicated that BF%, fat mass, and fat free mass improved 
over time for both the PLA and BA groups.  It should be noted that all of the aforementioned 
studies also included some sort of training intervention along with supplementation of BA.  
Interestingly, Walter et al. (2010) also indicated that the BA group had significant body mass 
increases, although researchers were unclear as to why.  According to Nana et al. (2012) any 
subjects that are undergoing a whole-body scan, using DEXA, must be in a rested, fasted, and 
euhydrated state. In the current study, participants were asked to come to the lab well hydrated 
and to have had some sort of breakfast, because they were engaging in volitional fatigue testing 
and needed to be well hydrated. One possible limitation of the study was that participants did not 
eat consistent meals on those days and could have been in a different state of hydration, which 
could cause variability in the results.  Contrary to expectations, the data indicated that the regions 
of interest (legs, arms, or trunk) showed no significant findings between groups or over time.  
 Because of the time of year, time commitment, and difficulty of the HIIT protocol this 
study had very low recruitment.  Further, the small sample size of the present study resulted in 
low statistical power and increased the risk of type II errors and may have contributed to the lack 
of significant findings that research has demonstrated.  Participants were not evenly matched 
between groups, in part some participants quit the study, which caused the groups to become 
unevenly balanced.  As neither menstrual cycles nor hormonal changes were not accounted for in 
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the present study, future studies could time training around certain phases of the menstrual cycle 
for more accuracy.  
Conclusions  
 To the best of our knowledge, this is one the first studies that utilized the rowing 
ergometer as a mode for non-elite rowers, and one of few that used recreationally active females.  
Although there were improvements in performance, it cannot be concluded that supplementing 
with beta-alanine combined with HIIT provides enhancements.  This study determined that HIIT 
had a significant impact on exercise performance, while the results did not show much from the 
additional BA supplementation.  Moreover, supplementation with beta-alanine may have more 
impact on exercise capacity (TTE, PPO) while HIIT can offer improvements in aerobic and 
anaerobic performance.  Furthermore, the results of the present study did not reveal any 
significant changes in body composition.  The lack of significance in this study may have been 
due to how we participants were matched and low sample size.  Future researchers should 
consider using a 3 or 4-c model to analyze body composition to take multiple factors into 
account and have participants come to the lab in a fasted and euhydrated state on a day when no 
other testing is taking place.  Additionally, a cross-over design would be preferred so that 
participants would receive the same treatments and matching would not be an issue.  Such a 
design is very time consuming and would require prolonged washout periods of at least 12 
weeks.  Future studies should also consider matching subjects based off of peak power, VO2 
peak, or total work done.  Although changes in muscle carnosine were not measured in this 
study, the dosing protocol was comparable to other studies (Harris et al., 2006) that showed a 
~60% increase in carnosine levels after 4 weeks of supplementation.  Given that beta-alanine is 
rate limiting pre-cursor for carnosine synthesis, it can be assumed that supplementing with this 
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ergogenic aid will elevate muscle carnosine content.  Ideally, future studies would measure 
carnosine content and blood lactate, as it could provide valuable data.  Finally, food diaries and 
compliance are complicating factors, as they are incredibly difficult to monitor because of 
honesty and memory recall. Additionally, future studies might want to use the rowing ergometer 
as a mode for recreationally active males or females as it can provide a whole body workout and 
consider using combined supplementation (beta-alanine, creatine, or sodium bicarbonate). 
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APPENDIX A 
Research Questions 
1. Was there a combined effect from BA supplementation and HIIT on VO2 peak, TTE,and 
body composition? 
2. Did supplementation with BA combined with HIIT on the rowing ergometer elicit 
changes in regional areas of interest (arms, trunk, or legs)? 
3. Will the combination of HIIT and BA supplementation reduce the time to complete a 
1,000 m time trial and increase peak power output? 
Assumptions 
1. That all participants will comply with dosing protocols. 
2. That all participants will accurately document their physical activity and food diaries. 
3. That all participants gave 100% during all pre and post testing procedures and during the 
training protocol. 
Limitations 
1. Only using women 18-35 
2. Did not control for menstrual cycles or hormonal changes 
3. Cannot control diet or exercise outside of the lab setting 
4. Compliance with placebo and beta-alanine supplementation 
Definitions 
1. ATP-PC System: metabolic pathway that uses ATP and phosphocreatine to 
rephosphorylate ADP.  It is used at the initial onset of exercise and during high intensity 
exercise. 
2. ADP (adenosine diphosphate): a molecule that combines with inorganic phosphate to 
form ATP. 
3. ATP (Adenosine triphosphate): high energy phosphate used by cells to release energy 
during work. 
4. H+ (Hydrogen Ions): free hydrogen ion in a solution that can result in a decrease in pH. 
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5. LIST Test (Loughborough Intermittent Sprint Testing): variable-intensity shuttle 
running over 20 m, mimics the characteristics of a soccer game. 
 
6. pKa: an index used to express the acidity of weak acids. 
7. YoYoIR2: test to evaluate ability of an individual to repeatedly perform and recover 
form intense exercise, while stimulating both the aerobic and anaerobic energy systems. 
8. DEXA (Dual energy-ray absorptiometry): a tool normally used to assess bone mineral 
content, but has been recently used to assess body composition using a three 
compartment model (fat mass, fat free mass, and bone mineral content).  Moreover, it can 
also assess whole body and regional estimates of fat %. 
9. BOD POD:  Gold standard device used for body composition measurement.  It uses air 
displacement plethysmography and whole body densitometry to determine body 
composition (fat and fat free mass).
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 
PAR-Q+ 
The Physical Activity Readiness Questionnaire for E v e r y o n e  
Regular physical activity is fun and healthy, and more people should become more physically active every day of the week.          Being 
more physically active is very safe for MOST people. This questionnaire will tell you whether it is necessary for you to          seek further 
advice from your doctor OR a qualified exercise professional before becoming more physically active. 
 SECTION 1 - GENERAL HEALTH  
 
Please read the 7 questions below carefully and answer each one honestly: check YES or NO. YES NO 
1. Has your doctor ever said that you have a heart condition OR high blood pressure?  
2. 
Do you feel pain in your chest at rest, during your daily activities of living, OR when you do physical 
activity? 
 
3. 
Do you lose balance because of dizziness OR have you lost consciousness in the last 12 months? 
Please answer NO if your dizziness was associated with over-breathing (including during vigorous 
exercise). 
 
4. 
Have you ever been diagnosed with another chronic medical 
condition (other than heart disease or high blood pressure)? 
 
5. Are you currently taking prescribed medications for a chronic medical condition?  
 
6. 
Do you have a bone or joint problem that could be made worse by becoming more physically active? 
Please answer NO if you had a joint problem in the past, but it does not limit your current ability to be 
physically active. For example, knee, ankle, shoulder or other. 
 

 

7. Has your doctor ever said that you should only do medically supervised physical activity?  
 
If you answered NO to all of the questions above, you are cleared for physical activity. 
 Go to Section 3 to sign the form. You do not need to complete Section 2. 
›   Start becoming much more physically active – start slowly and build up   gradually. 
›   Follow the Canadian Physical Activity Guidelines for your age (www.csep.ca/guidelines). 
›   You may take part in a health and fitness appraisal. 
› If you have any further questions, contact a qualified exercise professional such as a 
CSEP Certified Exercise Physiologist® (CSEP-CEP) or CSEP Certified Personal Trainer® 
(CSEP-CPT). 
› If you are over the age of 45 yrs. and NOT accustomed to regular vigorous physical activity, 
please consult a qualified exercise professional (CSEP-CEP) before engaging in maximal effort 
exercise. 
If you answered YES to one or more of the questions above, please GO TO SECTION 2 . 
Delay becoming more active if: 
› You are not feeling well because of a temporary illness such as a cold or fever – wait until you 
feel better 
› You are pregnant – talk to your health care practitioner, your physician, a qualified exercise 
professional, and/or complete the PAR med-X for Pregnancy before becoming more physically 
active OR 
› Your health changes – please answer the questions on Section 2 of this document and/or talk to 
your doctor or qualified exercise professional (CSEP-CEP or CSEP-CPT) before continuing with 
any physical activity  program.     
SECTION 2 - CHRONIC MEDICAL CONDITIONS  
 
 
! 
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Please read the questions below carefully and answer each one honestly: check YES or NO. YES NO 
 
 
1. 
 
 
Do you have Arthritis, Osteoporosis, or Back Problems? 

If yes, answer 
questions 
1a-1c 

If no, go to 
question 2 
 
1a. 
Do you have difficulty controlling your condition with medications or other 
physician-prescribed therapies? (Answer NO if you are not currently taking 
medications or other treatments) 
 

 

 
1b. 
Do you have joint problems causing pain, a recent fracture or fracture caused 
by osteoporosis or cancer, displaced vertebra (e.g., spondylolisthesis),  and/ 
or spondylolysis/pars defect (a crack in the bony ring on the back of the spinal 
column)? 
 

 

1c. 
Have you had steroid injections or taken steroid tablets regularly for more than 3 
months? 
 
 
 
2. 
 
 
Do you have Cancer of any kind? 

If yes, answer 
questions 
2a-2b 

If no, go to 
question 3 
2a. 
Does your cancer diagnosis include any of the following types: lung/bronchogenic, 
multiple myeloma (cancer of plasma cells), head, and neck? 
 
2b. Are you currently receiving cancer therapy (such as chemotherapy or   radiotherapy)?  
 
 
3. 
 
Do you have Heart Disease or Cardiovascular Disease? 
This includes Coronary Artery Disease, High Blood Pressure, Heart Failure, Diagnosed 
Abnormality of Heart Rhythm 

If yes, answer 
questions 
3a-3e 

If no, go to 
question 4 
 
3a. 
Do you have difficulty controlling your condition with medications or other 
physician-prescribed therapies? 
(Answer NO if you are not currently taking medications or other  treatments) 
 

 

3b. 
Do you have an irregular heart beat that requires medical management? 
(e.g. atrial fibrillation, premature ventricular contraction) 
 
3c. Do you have chronic heart failure?  
3d. 
Do you have a resting blood pressure equal to or greater than 160/90 mmHg with or 
without medication? (Answer YES if you do not know your resting blood pressure) 
 
3e. 
Do you have diagnosed coronary artery (cardiovascular) disease and have not 
participated in regular physical activity in the last 2 months? 
 
 
4. 
 
Do you have any Metabolic Conditions? 
This includes Type 1 Diabetes, Type 2 Diabetes, Pre-Diabetes 

If yes, answer 
questions 
4a-4c 

If no, go to 
question 5 
4a. Is your blood sugar often above 13.0 mmol/L? (Answer YES if you are not  sure)  
 
4b. 
Do you have any signs or symptoms of diabetes complications such as heart 
or vascular disease and/or complications affecting your eyes, kidneys, and the 
sensation in your toes and feet? 
 

 

4c. 
Do you have other metabolic conditions (such as thyroid disorders, pregnancy- 
related diabetes, chronic kidney disease, liver problems)? 
 
 
 
5. 
 
Do you have any Mental Health Problems or Learning Difficulties? 
This includes Alzheimer’s, Dementia, Depression, Anxiety Disorder, Eating Disorder, 
Psychotic Disorder, Intellectual Disability, Down  Syndrome) 

If yes, answer 
questions 
5a-5b 

If no, go to 
question 6 
 
5a. 
Do you have difficulty controlling your condition with medications or other 
physician-prescribed therapies? (Answer NO if you are not currently taking 
medications or other treatments) 
 

 

5b. Do you also have back problems affecting nerves or muscles?  
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Please read the questions below carefully and answer each one honestly: check YES or NO. YES NO 
 
 
6. 
 
Do you have a Respiratory Disease? 
This includes Chronic Obstructive Pulmonary Disease, Asthma, Pulmonary High 
Blood Pressure 

If yes, 
answer 
questions 
6a-6d 

If no, go to 
question 7 
 
6a. 
Do you have difficulty controlling your condition with medications or 
other physician-prescribed therapies? 
(Answer NO if you are not currently taking medications or other  treatments) 
 

 

6b. 
Has your doctor ever said your blood oxygen level is low at rest or during 
exercise and/or that you require supplemental oxygen therapy? 
 
 
6c. 
If asthmatic, do you currently have symptoms of chest tightness, wheezing, labored 
breathing, consistent cough (more than 2 days/week), or have you used your rescue 
medication more than twice in the last week? 
 

 

6d. 
Has your doctor ever said you have high blood pressure in the blood vessels of 
your lungs? 
 
 
 
7. 
 
 
Do you have a Spinal Cord Injury? This includes Tetraplegia and Paraplegia 

If yes, 
answer 
questions 
7a-7c 

If no, go to 
question 8 
 
7a. 
Do you have difficulty controlling your condition with medications or 
other physician-prescribed therapies? 
(Answer NO if you are not currently taking medications or other  treatments) 
 

 

7b. 
Do you commonly exhibit low resting blood pressure significant enough to 
cause dizziness, light-headedness, and/or fainting? 
 
7c. 
Has your physician indicated that you exhibit sudden bouts of high blood 
pressure (known as Autonomic Dysreflexia)? 
 
 
8. 
 
Have you had a Stroke? 
This includes Transient Ischemic Attack (TIA) or Cerebrovascular  Event 

If yes, 
answer 
questions 
8a-c 

If no, go to 
question 9 
 
8a. 
Do you have difficulty controlling your condition with medications or 
other physician-prescribed therapies? 
(Answer NO if you are not currently taking medications or other  treatments) 
 

 

8b. Do you have any impairment in walking or mobility?  
8c. 
Have you experienced a stroke or impairment in nerves or muscles in the past 6 
months? 
 
 
9. 
 
Do you have any other medical condition not listed above or do you live with two 
chronic conditions? 

If yes, 
answer 
questions 
9a-c 

If no, read 
the advice 
on page 4 
 
9a. 
Have you experienced a blackout, fainted, or lost consciousness as a result of a head 
injury within the last 12 months OR have you had a diagnosed concussion within the 
last 12 months? 
 

 

9b. 
Do you have a medical condition that is not listed 
(such as epilepsy, neurological conditions, and kidney problems)? 
 
9c. Do you currently live with two chronic conditions?  
 
Please proceed to Page 4 for recommendations for your current medical condition and sign this document. 
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PAR-Q+ 
If you answered NO to all of the follow-up questions about your medical condition, you are ready to 
become more physically active: 
›   It is advised that you consult a qualified exercise professional (e.g., a CSEP-CEP or CSEP-CPT) to h e l p  
you develop a safe and effective physical activity plan to meet your health   needs. 
› You are encouraged to start slowly and build up gradually – 20-60 min. of low- to moderate-intensity 
exercise, 3-5 days per week including aerobic and muscle strengthening   exercises. 
› As you progress, you should aim to accumulate 150 minutes or more of moderate-intensity physical 
activity per week. 
› If you are over the age of 45 yrs. and NOT accustomed to regular vigorous physical activity, please 
consult a qualified exercise professional (CSEP-CEP) before engaging in maximal effort    exercise. 
 
If you answered YES to one or more of the follow-up questions about your medical   condition: 
› You should seek further information from a licensed health care professional before becoming more 
physically active or engaging in a fitness appraisal and/or visit a or qualified exercise professional 
(CSEP-CEP) for further information. 
Delay becoming more active if: 
› You are not feeling well because of a temporary illness such as a cold or fever – wait until you feel better 
› You are pregnant - talk to your health care practitioner, your physician, a qualified exercise professional, 
and/or complete the PARmed-X for Pregnancy before becoming more physically active OR 
› Your health changes - please talk to your doctor or qualified exercise professional (CSEP-CEP) before 
continuing with any physical activity program. 
 SECTION  3  - DECLARATION  
›     You are encouraged to photocopy the PAR-Q+. You must use the entire questionnaire and NO changes are permitted. 
›   The Canadian Society for Exercise Physiology, the PAR-Q+ Collaboration, and their agents assume no liability for persons    
who undertake physical activity. If in doubt after completing the questionnaire, consult your doctor prior to physical activity. 
› If you are less than the legal age required for consent or require the assent of a care provider, your parent, guardian or care 
provider must also sign this form. 
›   Please read and sign the declaration below: 
I, the undersigned, have read, understood to my full satisfaction and completed this questionnaire. I acknowledge that      t his 
physical activity clearance is valid for a maximum of 12 months from the date it is completed and becomes invalid          if my 
condition changes. I also acknowledge  that  a  Trustee  (such  as  my  employer,  community/fitness  center,  health care 
provider, or other designate) may retain a copy of this form for their records. In these instances, the Trustee will be requ ired 
to adhere to local, national, and international guidelines regarding the storage of personal health information ensuring  that 
they maintain the privacy of the information and do not misuse or wrongfully disclose such information 
NAME  DATE    
 
SIGNATURE  WITNESS    
 
SIGNATURE OF PARENT/GUARDI
 
 
 
The PAR-Q+ was created using the evidence- 
based AGREE process (1) by the PAR-Q 
Collaboration    chaired    by    Dr.    Darren    E. 
R. Warburton with Dr. Norman Gledhill, Dr. 
Veronica Jamnik, and Dr. Donald C.  McKenzie  (2). 
Production of this document has been made 
possible through financial contributions from the 
Public Health Agency of Canada and the BC 
Ministry of Health Services. The views expressed 
herein do not necessarily represent the views of 
the Public Health Agency of Canada or BC Ministry 
of Health Services. 
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APPENDIX C 
TABLES & FIGURES 
 
TABLE 1: Subject Characteristics 
GROUP 
MEAN +/- STANDARD DEVIATION 
Age HEIGHT 
(cm) 
MASS (kg) 
PRE 
MASS (kg) 
POST 
BA (n=8) 21.38 ± 2.33 162.01 ± 6.44 62.56 ± 8.43 61.43 ± 5.84 
PLA (n=7) 23.86 ± 2.12 164.97 ± 7.46 66.67 ±  10.46 66.77 ±  10.09 
CON 
(n=6) 21.33 ± 0.82 164.08 ± 6.86 59.31 ± 4.9 59.32 ±  4.77 
TOTAL 
(n=21) 22.2 ± 2.2 163.69 ±  6.92 63 ±  8.52 62.61 ±  7.62 
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TABLES 
TABLE 2: Pre & Post Testing Results 
 
 
 
GROUP 
 
Mean +/- Standard Deviation 
Relative 
VO2 peak 
(ml/kg/min) 
TTE (seconds) 
during VO2 
VT as % of 
VO2 
TT (seconds) PPO (Watts) 
PRE POST PRE POST PRE POST PRE POST PRE POST 
BA (n=8) 34.49 ± 
4.46 
38.58 ± 
3.06 
441.25 ± 
73.25 
518.25 ± 
80.29 
58.13 ± 
9.11 
65.38 ± 
6.70 
272.88 ± 
17.74 
257.00 ± 
14.46 
241.25 ± 
23.63 
325.13 ± 
22.61 
PLA (n=7) 36.50 ± 
3.48 
41.83 ± 
6.58 
474.43 ± 
135.41 
573.86 ± 
115.12 
58.29 ± 
10.48 
61.29 ± 
7.65 
262.86 ± 
23.90 
249.14 ± 
22.97 
245.57 ± 
53.58 
378.71 ± 
72.23 
CON (n=6) 36.87 ± 
4.54 
37.10 ± 
5.48 
497.50 ± 
83.21 
477.00 ± 
94.53 
58.83 ± 
16.63 
65.17 ± 
7.94 
263.00 ± 
15.24 
261.82 ± 
14.55 
248.83 ± 
53.28 
254.50 ± 
40.60 
TOTAL 
(n=21) 
35.84 ± 
4.12 
39.24 ± 
5.26 * 
468.38 ± 
98.34 
524.67 ± 
99.89 * 
58.38 ± 
11.46 
63.95 ± 
7.26 * 
266.71 ± 
19.08 
255.76 ± 
17.65 * 
244.86 ± 
42.15 
322.81 ± 
68.20 * 
 
* Indicates that post testing values were significantly higher than the pre-testing values (p ≤ 0.05) 
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TABLE 3: Body Composition Results 
GROUP 
Body Composition Mean +/- Standard Deviation 
Total BF % Arm BF %  Trunk BF % Leg BF %  
PRE POST PRE POST PRE POST PRE  POST 
BA (n=8) 
33.25 +/-  
6.53 
32.99 +/-  
5.98 29.48 +/-  6.58 28.81 +/-  5.88 
32.94 +/-  
7.24 
32.43 +/-  
6.64 
35.01 +/-  
6.38 
35.24 +/-  
6.02 
PLA (n=7) 
29.83 +/-  
5.48 
28.61 +/-  
5.30 25.53 +/-  5.90 23.44 +/-  5.33 
28.54 +/-  
4.55 
26.89 +/-  
4.96 
32.76 +/-  
6.54 
31.70 +/-  
6.23 
CON (n=6) 
29.70 +/-  
4.78 
30.13 +/-  
4.73 25.67 +/-  4.91 25.07 +/-  5.68 
29.32 +/-  
5.80 
30.22 +/-  
5.68 
31.13 +/-  
4.08 
31.43 +/-  
4.03 
TOTAL 
(n=21) 31.10 +/- 5.71 
30.71 +/-  
5.50 27.07 +/-  5.10  25.95 +/-  5.86 * 
30.44 +/-  
6.10 
29.95 +/-  
6.05 
33.15 +/-  
5.82 
32.97 +/-  
5.63 
 
* Indicates that post testing values were significantly higher than the pre-testing values (p ≤ 0.05) 
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FIGURES 
 
 
 
Figure 1 Workload for periodized HIIT Protocol 
 
 
Figure 2 * (p ≤ 0.05). PPO was significantly higher during post testing for the BA and PLA 
groups as compared to the CON group 
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